34 related articles for article (PubMed ID: 24300751)
1. Adulteration of the Herbal Weight Loss Products by the Illegal Addition of Synthetic Antiobesity Medications: A Pilot Study.
Firozian F; Nili-Ahmadabadi A; Moradkhani S; Moulaei M; Fasihi Z; Ahmadimoghaddam D
J Obes; 2021; 2021():9968730. PubMed ID: 34336274
[TBL] [Abstract][Full Text] [Related]
2. Metformin for antipsychotic-induced weight gain: Statistical curiosities.
Pinto EF; George B; Karia S; Andrade C
J Psychopharmacol; 2017 Apr; 31(4):514. PubMed ID: 28347259
[No Abstract] [Full Text] [Related]
3. Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment.
Grywińska WB; Głowacka A
Postep Psychiatr Neurol; 2023 Sep; 32(3):128-137. PubMed ID: 38034507
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Agarwal SM; Stogios N; Ahsan ZA; Lockwood JT; Duncan MJ; Takeuchi H; Cohn T; Taylor VH; Remington G; Faulkner GEJ; Hahn M
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD013337. PubMed ID: 36190739
[TBL] [Abstract][Full Text] [Related]
5. Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis.
Zhuo C; Xu Y; Liu S; Li J; Zheng Q; Gao X; Li S; Jing R; Song X; Yue W; Zhou C; Upthegrove R
Front Pharmacol; 2018; 9():1393. PubMed ID: 30546312
[No Abstract] [Full Text] [Related]
6. Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment.
Schlienz NJ; Huhn AS; Speed TJ; Sweeney MM; Antoine DG
Int Rev Psychiatry; 2018 Oct; 30(5):147-154. PubMed ID: 30398080
[TBL] [Abstract][Full Text] [Related]
7. The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis.
Taylor J; Stubbs B; Hewitt C; Ajjan RA; Alderson SL; Gilbody S; Holt RI; Hosali P; Hughes T; Kayalackakom T; Kellar I; Lewis H; Mahmoodi N; McDermid K; Smith RD; Wright JM; Siddiqi N
PLoS One; 2017; 12(1):e0168549. PubMed ID: 28056018
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.
Peters-Strickland T; Baker RA; McQuade RD; Jin N; Eramo A; Perry P; Johnson BR; Duca A; Sanchez R
NPJ Schizophr; 2015; 1():15039. PubMed ID: 27336044
[TBL] [Abstract][Full Text] [Related]
9. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
Mizuno Y; Suzuki T; Nakagawa A; Yoshida K; Mimura M; Fleischhacker WW; Uchida H
Schizophr Bull; 2014 Nov; 40(6):1385-403. PubMed ID: 24636967
[TBL] [Abstract][Full Text] [Related]
11. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
[TBL] [Abstract][Full Text] [Related]
12. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
Himmerich H; Schuld A; Pollmächer T
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.
Gu XJ; Chen R; Sun CH; Zheng W; Yang XH; Wang SB; Ungvari GS; Ng CH; Golenkov A; Lok GKI; Li L; Chow IHI; Wang F; Xiang YT
J Int Med Res; 2018 Jan; 46(1):22-32. PubMed ID: 28718688
[TBL] [Abstract][Full Text] [Related]
14. Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophrenia.
Biedermann F; Fleischhacker WW; Kemmler G; Ebenbichler CF; Lechleitner M; Hofer A
Int Clin Psychopharmacol; 2014 May; 29(3):181-4. PubMed ID: 24300751
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
Henderson DC; Copeland PM; Daley TB; Borba CP; Cather C; Nguyen DD; Louie PM; Evins AE; Freudenreich O; Hayden D; Goff DC
Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
[TBL] [Abstract][Full Text] [Related]
16. Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
Baptista T; Uzcátegui E; Rangel N; El Fakih Y; Galeazzi T; Beaulieu S; de Baptista EA
Psychiatry Res; 2008 May; 159(1-2):250-3. PubMed ID: 18374423
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
